All In Biotech

Free tool

FAERS Monitor: Acthar Gel

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 008372 or its brand name (Acthar Gel, Corticotropin). Reports on generic versions are filed under their own applications.

Reports

4,450

Serious

1,711

38% of reports

Hospitalization

534

Death reported

61

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • injection site bruising385
  • fatigue381
  • product dose omission issue317
  • injection site pain301
  • headache268
  • insomnia255
  • condition aggravated198
  • weight increased198
  • pain191
  • drug ineffective180
  • blood glucose increased172
  • asthenia161
  • peripheral swelling154
  • injection site pruritus144
  • fluid retention140

Reports by year received

View as table
YearReports
20081
20091
20101
20117
201224
201346
201473
201565
201664
201777
2018104
201985
202041
202143
202247
202359
202463
202583
20263,566

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,709 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
injection site bruisingSignal38522.920.88,039
fluid retentionSignal14013.011.11,544
injection site pruritusSignal14410.28.71,184
product dose omission issueSignal3175.14.61,054
peripheral swellingSignal1544.74.0452
injection site painSignal3014.64.2868
insomniaSignal2554.54.0706
blood glucose increasedSignal1724.33.7439
weight increasedSignal1984.23.6481
condition aggravatedSignal1983.12.7280
fatigueSignal3812.32.1294
astheniaSignal1612.01.784
headacheSignal2682.01.8141
pain1911.51.329
drug ineffective1800.60.637

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.